The Medical Technologies Innovation Facility (MTIF) at the University of Nottingham will bring together £ 23 million organizations and clinicians with university researchers to develop their ideas and bring them to market as quickly as possible.
MTIF Building on Clifton Campus. Image credit: Henry Brothers
Work is now complete at the university’s Clifton Campus and at the Boots site on the Nottingham Enterprise Zone.
The MTIF project is expected to improve patient life, reduce the cost of care and stimulate the regional economy.
It focuses on supporting the development of innovative products and advanced products to meet a range of future healthcare needs and accelerate innovation.
The site on the Clifton Campus will focus on research and development, connecting academics with industry to provide a multidisciplinary approach to medical technology development.
The Boots site, meanwhile, will be dedicated to the development, clinical production and commercialization of new medical technologies. This site will provide access to laboratories, clean rooms, technologies and knowledge for processing, prototype development and preparation of manufacturing processes.
MTIF is expected to become a key specialist innovation fund within the Mediterranean Engine, supporting industry and strengthening the regional economy in the areas of life sciences and healthcare.
The project was supported by £ 9.7m from the D2N2 Local Enterprise Partnership, through the allocation of the Local Growth Fund. Henry Brothers and GF Tomlinson have been key contractors for the Clifton Campus and Boots site, respectively.
This development is a key part of NTU’s investment in ensuring the sustainability and economic growth of the City, County and District. ”
Professor Edward Peck, Vice-Chancellor, University of Nottingham Trent
MTIF Managing Director Mike Hannay said: “This is a very exciting development for Nottingham and the wider region. MTIF brings together companies, clinicians and university researchers to bring their ideas from the bench to the bedside, accelerating the pace of innovation to improve patient care. ”
D2N2 is proud to have invested over £ 9.7m from the Local Growth Fund in the Medical Technologies Innovation Facility (MTIF) at the Clifton NTU site and the Boots site, which is part of the Nottingham Enterprise Zone. Life sciences and healthcare are a key area for the D2N2 LEP, not only helping patients receive better treatment but also playing a dynamic role in driving the economic growth of the region. . ”
Sajeeda Rose, Chief Executive, D2N2 Local Enterprise Partnership
Source:
University of Nottingham Trent